Search
for
Sort by
Research 271–300 of 1000+
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Comparative Efficacy of Oral and Topical 5-Alpha Reductase Inhibitors in Reducing Dihydrotestosterone levels across Men with Androgenetic Alopecia: A Network Meta-Analysis incorporating Post-Hoc Analyses of Randomized Clinical Trial Data
- Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication
- Actions of 5α-reductase inhibitors on the epididymis
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- The relative effect of monotherapy with 5‐alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta‐analysis study
- A proposed etiopathology of persistent dysfunctions emerging from use and discontinuation of 5-alpha reductase inhibitors: sequelae of drug-mediated microvasculopathy
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- 5-Alpha reductase deficiency
- Novel prospectives of shikimic acid and Prunus mume extract for enhancing bioactivity on 5α-reductase and stability in cosmetic patches for acne treatment
- Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups
- The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
- An overview on 5α-reductase inhibitors
- 9 Role of 5α-reductase in health and disease
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- The connection of 5-alpha reductase inhibitors to the development of depression
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
- Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Novel C-6 substituted and unsubstituted pregnane derivatives as 5α-reductase inhibitors and their effect on hamster flank organs diameter size
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- Re: Association of Suicidality and Depression with 5α-Reductase Inhibitors
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation